The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 23, 2025

Filed:

Dec. 27, 2019
Applicant:

Wuhan Ll Science and Technology Development Co., Ltd., Hubei, CN;

Inventors:

Jun Lou, Hubei, CN;

Yongkai Chen, Hubei, CN;

Junhua Liu, Hubei, CN;

Yihan Zhang, Hubei, CN;

Xiaodan Guo, Hubei, CN;

Li Liu, Hubei, CN;

Lina Qian, Hubei, CN;

Chaodong Wang, Hubei, CN;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61P 11/14 (2006.01); C07D 209/18 (2006.01); C07D 413/06 (2006.01); C07D 487/04 (2006.01); C07D 491/048 (2006.01); C07F 5/04 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61P 11/14 (2018.01); C07D 209/18 (2013.01); C07D 413/06 (2013.01); C07D 487/04 (2013.01); C07D 491/048 (2013.01); C07F 5/04 (2013.01);
Abstract

Disclosed by the invention is a heterocyclic compound, an intermediate, and a preparation method therefor and an application thereof. Provided by the invention are a heterocyclic compound as shown in formula I, and a stereoisomer, a geometric isomer, a tautomer, a nitrogen oxide, a hydrate, a solvate, a metabolite, an ester, a pharmaceutically acceptable salt or a prodrug thereof. The heterocyclic compound has a high P2X3 antagonistic activity, and has good selectivity, low toxicity, good metabolic stability and little taste influence.


Find Patent Forward Citations

Loading…